Dr. Charmaine Jamias Ortizo, MD

Dr. Ortizo practices at Loma Linda University Medical Cente - Center for Restorative Neurology - HOPD in Loma Linda, California.

Dr. Ortizo's NPI, 1689051120, was assigned on May 5, 2015. Dr. Ortizo graduated from George Washington University School of Medicine and Health Sciences in 2015. Dr. Ortizo holds California license A147836.

Dr. Ortizo's primary practice is Loma Linda University Medical Cente - Center for Restorative Neurology - HOPD, at 11370 Anderson St, Loma Linda, CA 92354.

Dr. Ortizo's primary practice is Loma Linda University Medical Cente - Center for Restorative Neurology - HOPD in Loma Linda, California. Dr. Ortizo is also affiliated with Loma Linda University Medical Center. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Ortizo to 1 more hospital, 2 home health agencies and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ortizo practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Ortizo's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Ortizo is board certified in internal medicine by the American Board of Internal Medicine. Dr. Ortizo is licensed in California.

Dmand AI lists acid reflux, acute kidney failure, acute sinusitis, acute skin infection, acute stomach ulcer, ankle or foot injury, anxiety and arthritis among the conditions Dr. Ortizo treats.

CMS data shows 557 Medicare services from Dr. Ortizo across 9 procedure codes in 2024, for 275 Medicare patients. Medicare paid $43,087 for them.

CMS counts 275 Medicare patients who saw Dr. Ortizo in 2024. The largest group is 65 to 74, with 96 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 34% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ortizo's median patient age at 70, with 62% women.

In 2024, Dr. Ortizo wrote 2,886 Medicare Part D claims for 423 patients. 86% of them were for generic drugs. CMS names the drug for 2,204 of them, across 59 drugs with 11 or more claims each, at $129,789 in total drug cost. In 2023, CMS named 3,078 claims across 82 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Ortizo for performance year 2024, reported as part of a group. Dr. Ortizo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ortizo as offering telehealth.

CMS Open Payments shows 1 general payment to Dr. Ortizo from 1 drug or device company in 2021. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $27.

Dr. Ortizo graduated from George Washington University School of Medicine and Health Sciences in 2015.

Dr. Ortizo is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.